Kamada Ltd.
Kibbutz Beit Kama M.P.
Negev
85325
Tel: 07-991-2082
Fax: 07-991-2083
252 articles about Kamada Ltd.
-
Kamada Ltd. Announces Initiation Of A Phase 2 U.S. Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency
3/24/2014
-
Kamada Ltd. To Report Top-Line Data From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency By Late April Or Early May
3/21/2014
-
Kamada Ltd. Initiates Phase 2/3 Clinical Trial Of Glassia To Treat Newly Diagnosed Pediatric Patients With Type 1 Diabetes
3/5/2014
-
Kamada Ltd. Completes Enrollment In U.S. Pivotal Clinical Trial With Kamrab As A Post-Exposure Treatment For Rabies
3/4/2014
-
Kamada Ltd. To Ring The NASDAQ Stock Market Opening Bell On February 25, 2014
2/24/2014
-
Kamada Ltd. Reports 2013 Fourth Quarter And Full Year Financial Results
2/5/2014
-
Kamada Ltd. To Host Fourth Quarter And Full Year 2013 Financial Results Conference Call On Wednesday, February 5, 2014
1/31/2014
-
Kamada Ltd. Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency
12/11/2013
-
Kamada Ltd. Announces Appointment Of Amir London As Senior Vice President, Business Development
12/9/2013
-
Kamada Ltd. Reports New Data From an Extension Study of Its Phase I/II Trial With Glassia in Pediatric Patients With Type 1 Diabetes
10/31/2013
-
Kamada Ltd. Reports Third Quarter 2013 Financial Results
10/29/2013
-
Kamada Ltd. to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, October 29, 2013
10/22/2013
-
Kamada Ltd. to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, October 29, 2013
10/22/2013
-
Kamada Ltd. to Present at September Investment Conferences
9/4/2013
-
Kamada Ltd. Reports Second Quarter 2013 Financial Results
8/1/2013
-
Kamada Ltd. to Host Second Quarter 2013 Financial Results Conference Call on Thursday, August 1, 2013
7/25/2013
-
Study Demonstrating Pancreatic Islet Xenograft Survival With Kamada Ltd.'s AAT Published in Peer-Reviewed Publication
7/10/2013
-
Kamada Ltd. Granted Two Key Patents
6/24/2013
-
Kamada Ltd. Announces Pricing of Initial Public Offering
6/5/2013
-
Kamada Ltd. Announces Closing of Initial Public Offering and Over-Allotment Option Exercise
6/5/2013